(Q38467635)

English

Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model

scientific article published on August 1999

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Catalona WJ

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Partin AW

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Finlay JA

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Chan DW

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Rittenhouse HG

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Wolfert RL

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Woodrum DL

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

0 references

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

220-224

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Longitudinal screening for prostate cancer with prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900185-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900185-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900185-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900185-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900185-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900185-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Percentage of free serum prostate-specific antigen as a predictor of pathologic features of prostate cancer in a screening population

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900185-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of percent free prostate specific antigen for staging clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900185-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900185-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Free to total prostate-specific antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSA

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900185-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-year stability of free and total PSA in frozen serum samples

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900185-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900185-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The appropriate lower limit for the percent free prostate-specific antigen reflex range

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900185-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(99)00185-5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38467635&oldid=1760984188"